Literature DB >> 6125583

Identification of the beta adrenergic receptor subtype on astroglia purified from rat brain.

T K Harden, K D McCarthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6125583

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  8 in total

1.  Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neocortical explants is seen only with the beta-1, not with the beta-2 subtype.

Authors:  G J Boer; A A Kellerman; R E Baker; P te Riele; M G Feenstra; M Botterblom; B H Erdtsieck-Ernste
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

2.  Distribution and subtype determination of beta-receptors in the spinal cord of the adult rat.

Authors:  E Schrader; H Grobecker
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

Review 3.  Primary astrocyte cultures--a key to astrocyte function.

Authors:  H K Kimelberg
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

Review 4.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

5.  Activation of beta-adrenergic receptors stimulates taurine release from glial cells.

Authors:  W G Shain; D L Martin
Journal:  Cell Mol Neurobiol       Date:  1984-06       Impact factor: 5.046

6.  ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.

Authors:  J A Nathanson
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

7.  Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.

Authors:  R P Mohney; R E Zigmond
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 8.  β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma.

Authors:  George Zaki Ghali; Michael George Zaki Ghali
Journal:  Mol Biol Rep       Date:  2020-04-18       Impact factor: 2.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.